• Aethlon Medical Inc AEMD.OQ reported a quarterly adjusted loss of 13 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of $-1.37. The mean expectation of three analysts for the quarter was for a loss of 21 cents per share. Wall Street expected results to range from -23 cents to -20 cents per share.

• Reported revenue was zero​; analysts expected zero.

• Aethlon Medical Inc's reported EPS for the quarter was a loss of 13 cents​.

• The company reported a quarterly loss of $1.75 million.

• Aethlon Medical Inc shares had fallen by 20.7% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 0.8% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Aethlon Medical Inc is $3.86

This summary was machine generated from LSEG data February 12 at 11:38 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)